- Home
- AGEN vs FFIE Comparison
AGEN vs FFIE Comparison
Compare AGEN & FFIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- FFIE
- Stock Information
- Founded
- AGEN 1994
- FFIE 2014
- Country
- AGEN United States
- FFIE United States
- Employees
- AGEN N/A
- FFIE N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- FFIE Auto Manufacturing
- Sector
- AGEN Health Care
- FFIE Consumer Discretionary
- Exchange
- AGEN Nasdaq
- FFIE Nasdaq
- Market Cap
- AGEN 96.2M
- FFIE 97.5M
- IPO Year
- AGEN 2000
- FFIE N/A
- Fundamental
- Price
- AGEN $3.32
- FFIE $1.60
- Analyst Decision
- AGEN Buy
- FFIE
- Analyst Count
- AGEN 3
- FFIE 0
- Target Price
- AGEN $10.50
- FFIE N/A
- AVG Volume (30 Days)
- AGEN 357.6K
- FFIE 11.5M
- Earning Date
- AGEN 03-13-2025
- FFIE 11-06-2024
- Dividend Yield
- AGEN N/A
- FFIE N/A
- EPS Growth
- AGEN N/A
- FFIE N/A
- EPS
- AGEN N/A
- FFIE N/A
- Revenue
- AGEN $160,427,000.00
- FFIE $537,000.00
- Revenue This Year
- AGEN N/A
- FFIE $10,958.67
- Revenue Next Year
- AGEN $26.02
- FFIE $617.65
- P/E Ratio
- AGEN N/A
- FFIE N/A
- Revenue Growth
- AGEN 59.00
- FFIE N/A
- 52 Week Low
- AGEN $2.50
- FFIE $0.99
- 52 Week High
- AGEN $19.69
- FFIE $156.00
- Technical
- Relative Strength Index (RSI)
- AGEN 45.96
- FFIE 51.72
- Support Level
- AGEN $3.09
- FFIE $1.49
- Resistance Level
- AGEN $3.68
- FFIE $1.86
- Average True Range (ATR)
- AGEN 0.25
- FFIE 0.18
- MACD
- AGEN -0.03
- FFIE 0.04
- Stochastic Oscillator
- AGEN 23.00
- FFIE 46.84
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About FFIE Faraday Future Intelligent Electric Inc.
Faraday Future Intelligent Electric Inc is a global shared intelligent mobility ecosystem. It is poised to break the boundaries between the Internet, IT, creative, and auto industries with product and service offerings that integrate new energy, AI, Internet, and sharing models.